AlphaStocks
5.8
Consider Buy

BECTON DICKINSON & CO (BDX)

Health Care / Health Care Equipment

S&P 500

$144.64

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#299out of 1126 in Health Care

Is BECTON DICKINSON & CO a Good Investment in 2026?

BECTON DICKINSON & CO (BDX) scores 5.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates BECTON DICKINSON & CO as Strong. However, the Lynch model rates it Caution — High PEG — growth premium · Slow Grower. BECTON DICKINSON & CO currently trades below its estimated fair value of $149, suggesting potential upside. BECTON DICKINSON & CO ranks #299 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E24.9ROE6.6Market Cap41BDiv Yield2.9

Estimated Fair Value

$149.033% below

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Strong

Business quality & competitive moat

Graham

Caution

35% above fair value

Lynch

Caution

High PEG — growth premium · Slow Grower

Greenblatt

Strong

Top 10% (rank 7%)

Frequently Asked Questions

Is BECTON DICKINSON & CO (BDX) a good investment?
Based on AlphaStocks' composite analysis, BECTON DICKINSON & CO (BDX) scores 5.8 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading near estimated fair value.
What is BECTON DICKINSON & CO's Piotroski F-Score?
BECTON DICKINSON & CO's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is BDX overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $149, BDX appears undervalued. The stock currently trades 3% below its estimated fair value. Trading near estimated fair value.
How does BDX compare to other Health Care stocks?
BECTON DICKINSON & CO ranks #299 out of 1126 stocks in the Health Care sector, placing it in the top 27% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about BDX?
AlphaStocks evaluates BDX using five proven investment models. Piotroski: Attractive; Buffett: Strong; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 5.8/10.

Similar Stocks

PARRAZNFTI

Compare BDX with

BDX vs PARRBDX vs AZNBDX vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer